nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Comparison of the Clinical Outcomes of Haploidentical Transplantation and Other Graft Sources in Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis
|
Owattanapanich, Weerapat |
|
|
22 |
3 |
p. 174-191 |
artikel |
2 |
Bing-Neel Syndrome: Update on the Diagnosis and Treatment
|
Nanah, Abdelrahman |
|
|
22 |
3 |
p. e213-e219 |
artikel |
3 |
Brentuximab Vedotin and Bendamustine Produce Long-Term Clinical Benefit in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma: A Multicenter Real-Life Experience
|
Moretti, Marina |
|
|
22 |
3 |
p. 198-204 |
artikel |
4 |
Editorial Board
|
|
|
|
22 |
3 |
p. A1-A2 |
artikel |
5 |
Effect of t (11;14) Abnormality on Outcomes of Patients With Newly Diagnosed Multiple Myeloma in the Connect MM Registry
|
Gasparetto, Cristina |
|
|
22 |
3 |
p. 149-157 |
artikel |
6 |
FMS-Like Tyrosine Kinase 3 Inhibitors for the Treatment of Acute Myeloid Leukemia
|
Novatcheva, Elli D. |
|
|
22 |
3 |
p. e161-e184 |
artikel |
7 |
Health-Related Quality of Life, Symptoms, and Tolerability of Loncastuximab Tesirine in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
|
Spira, Alexander |
|
|
22 |
3 |
p. 158-168 |
artikel |
8 |
Impact of Radiation Therapy After High Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation in Patients With Relapsed/Refractory Lymphomas: A Single Center Experience
|
Osmani, Asif Husain |
|
|
22 |
3 |
p. e149-e160 |
artikel |
9 |
Injectable Hypomethylating Agents for Management of Myelodysplastic Syndromes: Patients’ Perspectives on Treatment
|
Zeidan, Amer M. |
|
|
22 |
3 |
p. e185-e198 |
artikel |
10 |
Prognostic of Core Binding Factor (CBF) Acute Myeloid Leukemia With Complex Karyotype
|
Marcault, Clemence |
|
|
22 |
3 |
p. e199-e205 |
artikel |
11 |
Refractory DLBCL: Challenges and Treatment
|
Goldfinger, Mendel |
|
|
22 |
3 |
p. 140-148 |
artikel |
12 |
SOHO State of the Art Updates and Next Questions: Harnessing Apoptosis in AML
|
Saxena, Kapil |
|
|
22 |
3 |
p. 133-139 |
artikel |
13 |
Table of Contents
|
|
|
|
22 |
3 |
p. A3-A4 |
artikel |
14 |
The Real‐World Experience With Single Agent Ibrutinib in Relapsed/Refractory CLL
|
Akpinar, Seval |
|
|
22 |
3 |
p. 169-173 |
artikel |
15 |
The Safety and Efficacy of Radiation Therapy with Concurrent Dexamethasone, Cyclophosphamide, Etoposide, and Cisplatin-Based Systemic Therapy for Multiple Myeloma
|
Nehlsen, Anthony D. |
|
|
22 |
3 |
p. 192-197 |
artikel |
16 |
Validation of AML-score in Older Adults Receiving CPX-351 Intensive Induction Chemotherapy for Treatment of Secondary Acute Myeloid Leukemia
|
Schmucker, Abigail M. |
|
|
22 |
3 |
p. e206-e212 |
artikel |